Thromboembolic Risks of Activated Factor VIIa Use in Warfarin-Associated Intracerebral Hemorrhage
Thromboembolic Risks of Activated Factor VIIa Use in Warfarin-Associated Intracerebral Hemorrhage. Critical Care Med 2009 Vol 37, No. 12 (suppl) A422. 2009; 37(12):A422.